[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avai Bio Inc (AVAI)

Avai Bio Inc (AVAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks in play: Avai Bio Inc

Announced that, together with its joint venture partner Austrianova, it has successfully concluded negotiations ...

AVAI : 0.1149 (-11.62%)
Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:NVO),(NASDAQ:SNY),(NASDAQ:DXCM),(NASDAQ:TNDM) EQNX::TICKER_END

AVAI : 0.1149 (-11.62%)
TNDM : 19.01 (+2.26%)
NVO : 51.61 (+0.06%)
DXCM : 74.54 (-0.80%)
SNY : 42.89 (-4.37%)
Stocks in play: Avai Bio Inc

Announced together with its joint venture partner and global biotechnology firm, Austrianova— a major ...

AVAI : 0.1149 (-11.62%)
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GERN),(NASDAQ:BIOA),(NYSE:LCTX),(NASDAQ:FATE) EQNX::TICKER_END

AVAI : 0.1149 (-11.62%)
BIOA : 24.85 (+11.99%)
LCTX : 1.1100 (+4.72%)
GERN : 1.3400 (-4.29%)
FATE : 2.51 (+6.36%)
Stocks in play: Avai Bio Inc (QB)

Announced that in collaboration with its joint venture partner, Austrianova, a global biotechnology ...

AVAI : 0.1149 (-11.62%)
Biotech Brief: Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference

Las Vegas, NV – April 7, 2026 – Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related...

AVAI : 0.1149 (-11.62%)
Stocks in play: Avai Bio Inc

Announced--together with its joint venture partner and global biotechnology firm, Austrianova--the initiation ...

AVAI : 0.1149 (-11.62%)
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GERN),(NASDAQ:NTLA),(NASDAQ:NAGE),(NASDAQ:OCGN) EQNX::TICKER_END

AVAI : 0.1149 (-11.62%)
NAGE : 3.32 (+3.11%)
GERN : 1.3400 (-4.29%)
NTLA : 11.09 (+2.69%)
OCGN : 1.2600 (+5.88%)
Stocks in play: Avant Technologies Inc

Announced the completion of its corporate name change to Avaí Bio, Inc. The rebranding, effective today, ...

AVAI : 0.1149 (-11.62%)
Stocks in play: Avant Technologies Inc

Announced its participation in the 15th European Pancreas and Islet Transplantation Association (EPITA) ...

AVAI : 0.1149 (-11.62%)

Barchart Exclusives

Here’s Why Verizon Stock Is a Buy for Income Investors in August
A safer dividend, stronger free cash flow, and new growth opportunities make Verizon increasingly attractive for income-focused investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.